Skip to content

Effect of Drainage on the Incidence of Seroma After Laparoscopic Trans Abdominal Preperitoneal Inguinal Hernia Repair

Evaluating the Effect of Drainage on the Incidence of Seroma After Laparoscopic Trans Abdominal Preperitoneal Inguinal Hernia Repair

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07681700
Enrollment
48
Registered
2026-07-02
Start date
2024-12-01
Completion date
2025-10-01
Last updated
2026-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drainage, Laparoscopic, Preperitoneal Inguinal Hernia Repair, Seroma, Trans-abdominal

Brief summary

The aim of the study is to evaluate the effect of drainage on the incidence of seroma after laparoscopic transabdominal preperitoneal inguinal hernia repair.

Detailed description

Inguinal hernia repair is one of the most common surgical conditions encountered in primary care settings. Globally, around 20 million groin hernia repairs are performed each year. Surgical procedure is the gold standard treatment for inguinal hernia repair. Laparoscopic hernioplasty is suitable for patients with inguinal hernia who can undergo general anesthesia, especially in cases like hernia recurrence after open repair, bilateral hernias, and simultaneous procedures like cholecystectomy. Although open mesh repair has already demonstrated a low recurrence rate, laparoscopic mesh repair has become increasingly popular in recent years due to its benefits, including a better view of the groin anatomy, ease in addressing bilateral hernias, and superior cosmetic outcomes. The two most widely used laparoscopic mesh repair techniques are Totally Extra peritoneal (TEP) and Trans abdominal Preperitoneal (TAPP) repair, both of which are based on the myopectineal orifice theory. The key difference between TEP and TAPP lies in the method used to access the preperitoneal space.

Interventions

PROCEDURETrans-abdominal preperitoneal repair + Drainage

Patients underwent the trans-abdominal preperitoneal (TAPP) repair technique with closed suction drain was placed through the lateral 5 mm port.

PROCEDURETrans-abdominal preperitoneal repair

Patients underwent the trans-abdominal preperitoneal (TAPP) repair technique but the drain wasn't applied.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged from18 to 70 years. * Both sexes. * Patients were diagnosed with all types of inguinal hernia who are candidates for elective trans-abdominal Preperitoneal (TAPP) repair.

Exclusion criteria

* Previous history of pelvic or lower abdominal surgery. * Coagulopathy. * Any condition contraindicating laparoscopic surgery. * Patients with complicated hernia (irreducible/incarcerated or obstructed/strangulated hernia). * Active infections. * Uncorrected medical comorbidities. * Bilateral inguinal hernia either preoperative or intraoperative diagnosis.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of patients suffering from Seroma6 months post-procedureIncidence of patients suffering from Seroma in each group after Transabdominal preperitoneal inguinal hernia repair.

Secondary

MeasureTime frameDescription
Degree of pain24 hours post-procedurePain was assessed using Visual Analogue Scale (VAS) in which the pain score is defined from 0 (no pain) to 10 (maximum pain) at rest and during activity recorded at similar intervals.
Degree of patient satisfaction24 hours post-procedureDegree of patient satisfaction was assessed using 3-likert point scale where (1, Neutral; 2, Satisfied; 3, Very satisfied)
Measurement of operative timeTill closure of the skin (Up to 60 minutes).Measurement of operative time was done from skin incision to closure.
Incidence of recurrence6 months post-procedureIncidence of recurrence of hernia was assessed during follow-up visits.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 3, 2026